ModivCare Inc. (MODV)
USD 11.78
(-16.42%)
USD 11.78
(-16.42%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.75 Billion USD | 9.85% |
| 2022 | 2.5 Billion USD | 25.41% |
| 2021 | 1.99 Billion USD | 45.9% |
| 2020 | 1.36 Billion USD | -9.36% |
| 2019 | 1.5 Billion USD | 9.02% |
| 2018 | 1.38 Billion USD | -14.71% |
| 2017 | 1.62 Billion USD | 2.85% |
| 2016 | 1.57 Billion USD | -6.87% |
| 2015 | 1.69 Billion USD | 14.47% |
| 2014 | 1.48 Billion USD | 31.93% |
| 2013 | 1.12 Billion USD | 1.52% |
| 2012 | 1.1 Billion USD | 17.28% |
| 2011 | 942.98 Million USD | 7.19% |
| 2010 | 879.69 Million USD | 9.82% |
| 2009 | 801.01 Million USD | 15.81% |
| 2008 | 691.67 Million USD | 142.55% |
| 2007 | 285.16 Million USD | 48.63% |
| 2006 | 191.85 Million USD | 31.67% |
| 2005 | 145.7 Million USD | 50.27% |
| 2004 | 96.96 Million USD | 63.58% |
| 2003 | 59.27 Million USD | 160.67% |
| 2002 | 22.73 Million USD | -99.09% |
| 2001 | 2.5 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 684.45 Million USD | -2.62% |
| 2024 Q2 | 698.29 Million USD | 2.02% |
| 2023 Q3 | 686.92 Million USD | -1.74% |
| 2023 Q4 | 702.83 Million USD | 2.32% |
| 2023 FY | 2.75 Billion USD | 9.85% |
| 2023 Q1 | 662.3 Million USD | 1.28% |
| 2023 Q2 | 699.1 Million USD | 5.56% |
| 2022 Q3 | 647.78 Million USD | 3.11% |
| 2022 Q4 | 653.92 Million USD | 0.95% |
| 2022 FY | 2.5 Billion USD | 25.41% |
| 2022 Q2 | 628.21 Million USD | 9.35% |
| 2022 Q1 | 574.47 Million USD | -0.23% |
| 2021 Q3 | 493.05 Million USD | 3.92% |
| 2021 Q1 | 453.61 Million USD | 13.83% |
| 2021 FY | 1.99 Billion USD | 45.9% |
| 2021 Q2 | 474.44 Million USD | 4.59% |
| 2021 Q4 | 575.77 Million USD | 16.78% |
| 2020 FY | 1.36 Billion USD | -9.36% |
| 2020 Q1 | 367.29 Million USD | -4.56% |
| 2020 Q2 | 282.25 Million USD | -23.15% |
| 2020 Q3 | 320.61 Million USD | 13.59% |
| 2020 Q4 | 398.5 Million USD | 24.29% |
| 2019 Q3 | 393.38 Million USD | 8.1% |
| 2019 FY | 1.5 Billion USD | 9.02% |
| 2019 Q1 | 367.81 Million USD | 1.96% |
| 2019 Q2 | 363.91 Million USD | -1.06% |
| 2019 Q4 | 384.83 Million USD | -2.17% |
| 2018 Q2 | 411.79 Million USD | 1.42% |
| 2018 Q4 | 360.76 Million USD | -14.37% |
| 2018 FY | 1.38 Billion USD | -14.71% |
| 2018 Q1 | 406.04 Million USD | -0.21% |
| 2018 Q3 | 421.31 Million USD | 2.31% |
| 2017 Q2 | 407.98 Million USD | 2.12% |
| 2017 FY | 1.62 Billion USD | 2.85% |
| 2017 Q4 | 406.88 Million USD | -0.64% |
| 2017 Q3 | 409.51 Million USD | 0.38% |
| 2017 Q1 | 399.49 Million USD | 3.51% |
| 2016 FY | 1.57 Billion USD | -6.87% |
| 2016 Q4 | 385.96 Million USD | -6.44% |
| 2016 Q3 | 412.51 Million USD | -8.46% |
| 2016 Q2 | 450.63 Million USD | 4.16% |
| 2016 Q1 | 432.65 Million USD | 1.82% |
| 2015 Q3 | 432.45 Million USD | -14.91% |
| 2015 Q2 | 508.25 Million USD | 0.49% |
| 2015 Q1 | 505.79 Million USD | 11.51% |
| 2015 FY | 1.69 Billion USD | 14.47% |
| 2015 Q4 | 424.92 Million USD | -1.74% |
| 2014 Q1 | 289.4 Million USD | 4.54% |
| 2014 Q2 | 343.95 Million USD | 18.85% |
| 2014 Q3 | 394.21 Million USD | 14.61% |
| 2014 Q4 | 453.59 Million USD | 15.06% |
| 2014 FY | 1.48 Billion USD | 31.93% |
| 2013 Q3 | 276.71 Million USD | -3.8% |
| 2013 Q2 | 287.63 Million USD | 2.18% |
| 2013 FY | 1.12 Billion USD | 1.52% |
| 2013 Q4 | 276.84 Million USD | 0.05% |
| 2013 Q1 | 281.48 Million USD | -1.76% |
| 2012 Q3 | 280.28 Million USD | 0.48% |
| 2012 Q4 | 286.51 Million USD | 2.22% |
| 2012 FY | 1.1 Billion USD | 17.28% |
| 2012 Q1 | 260.14 Million USD | 6.48% |
| 2012 Q2 | 278.93 Million USD | 7.22% |
| 2011 Q3 | 235.55 Million USD | 0.1% |
| 2011 Q1 | 227.8 Million USD | 3.9% |
| 2011 Q2 | 235.31 Million USD | 3.29% |
| 2011 Q4 | 244.31 Million USD | 3.72% |
| 2011 FY | 942.98 Million USD | 7.19% |
| 2010 Q4 | 219.26 Million USD | 0.97% |
| 2010 Q2 | 222.32 Million USD | 0.62% |
| 2010 Q3 | 217.15 Million USD | -2.33% |
| 2010 Q1 | 220.95 Million USD | 2.46% |
| 2010 FY | 879.69 Million USD | 9.82% |
| 2009 FY | 801.01 Million USD | 15.81% |
| 2009 Q1 | 186.71 Million USD | 4.9% |
| 2009 Q4 | 215.64 Million USD | 4.27% |
| 2009 Q3 | 206.82 Million USD | 7.81% |
| 2009 Q2 | 191.83 Million USD | 2.74% |
| 2008 FY | 691.67 Million USD | 142.55% |
| 2008 Q4 | 177.98 Million USD | 6.58% |
| 2008 Q3 | 166.99 Million USD | -3.48% |
| 2008 Q2 | 173.02 Million USD | -0.37% |
| 2008 Q1 | 173.66 Million USD | 76.01% |
| 2007 Q1 | 60.45 Million USD | 8.08% |
| 2007 Q2 | 62.31 Million USD | 3.07% |
| 2007 FY | 285.16 Million USD | 48.63% |
| 2007 Q3 | 63.73 Million USD | 2.28% |
| 2007 Q4 | 98.66 Million USD | 54.81% |
| 2006 Q2 | 45.84 Million USD | 6.54% |
| 2006 Q1 | 43.02 Million USD | 4.67% |
| 2006 Q4 | 55.93 Million USD | 18.89% |
| 2006 FY | 191.85 Million USD | 31.67% |
| 2006 Q3 | 47.05 Million USD | 2.64% |
| 2005 Q1 | 32.03 Million USD | 8.17% |
| 2005 Q2 | 65.21 Million USD | 103.6% |
| 2005 Q3 | 37.34 Million USD | -42.74% |
| 2005 Q4 | 41.1 Million USD | 10.07% |
| 2005 FY | 145.7 Million USD | 50.27% |
| 2004 Q2 | 20.67 Million USD | 12.05% |
| 2004 FY | 96.96 Million USD | 63.58% |
| 2004 Q1 | 18.45 Million USD | 12.89% |
| 2004 Q4 | 29.61 Million USD | 4.94% |
| 2004 Q3 | 28.21 Million USD | 36.46% |
| 2003 Q4 | 16.34 Million USD | 10.2% |
| 2003 FY | 59.27 Million USD | 160.67% |
| 2003 Q3 | 14.83 Million USD | 1.05% |
| 2003 Q2 | 14.68 Million USD | 54.3% |
| 2003 Q1 | 9.51 Million USD | 0.0% |
| 2002 FY | 22.73 Million USD | -99.09% |
| 2001 Q3 | 493.05 Million USD | 3.92% |
| 2001 Q4 | 575.77 Million USD | 16.78% |
| 2001 FY | 2.5 Billion USD | 0.0% |
| 2001 Q2 | 474.44 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 6.063% |
| Addus HomeCare Corporation | 1.05 Billion USD | -159.875% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -1304.253% |
| Amedisys, Inc. | 2.23 Billion USD | -23.019% |
| American Oncology Network, Inc. | 1.27 Billion USD | -115.072% |
| Astrana Health, Inc. | 1.38 Billion USD | -98.402% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | -45.164% |
| IMAC Holdings, Inc. | 5.19 Million USD | -52837.656% |
| biote Corp. | 185.36 Million USD | -1384.231% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -8677.427% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | -36.215% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -340.689% |
| The Ensign Group, Inc. | 3.72 Billion USD | 26.229% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -64.604% |
| InnovAge Holding Corp. | 763.85 Million USD | -260.169% |
| Assure Holdings Corp. | 255 Thousand USD | -1078790.196% |
| The Joint Corp. | 117.69 Million USD | -2237.515% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -160.61% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -26459.497% |
| NewGenIvf Group Limited | 5.13 Million USD | -53464.798% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -21783.279% |
| Option Care Health, Inc. | 4.3 Billion USD | 36.054% |
| P3 Health Partners Inc. | 1.26 Billion USD | -117.248% |
| P3 Health Partners Inc. | 1.26 Billion USD | -117.248% |
| The Pennant Group, Inc. | 544.89 Million USD | -404.903% |
| Surgery Partners, Inc. | 2.74 Billion USD | -0.287% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -49783.92% |
| Talkspace, Inc. | 150.04 Million USD | -1733.563% |
| Talkspace, Inc. | 150.04 Million USD | -1733.563% |
| The Oncology Institute, Inc. | 324.23 Million USD | -748.501% |
| The Oncology Institute, Inc. | 324.23 Million USD | -748.501% |